Cargando…
A First-in-Class Drug, Lomitapide, Tailored to Patients with Homozygous Familial Hypercholesterolemia is Just about Meeting with Good News to Them
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Japan Atherosclerosis Society
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392476/ https://www.ncbi.nlm.nih.gov/pubmed/28239069 http://dx.doi.org/10.5551/jat.ED069 |
| _version_ | 1783229451455168512 |
|---|---|
| author | Yoshida, Hiroshi |
| author_facet | Yoshida, Hiroshi |
| author_sort | Yoshida, Hiroshi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5392476 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Japan Atherosclerosis Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-53924762017-04-24 A First-in-Class Drug, Lomitapide, Tailored to Patients with Homozygous Familial Hypercholesterolemia is Just about Meeting with Good News to Them Yoshida, Hiroshi J Atheroscler Thromb Editorial Japan Atherosclerosis Society 2017-04-01 /pmc/articles/PMC5392476/ /pubmed/28239069 http://dx.doi.org/10.5551/jat.ED069 Text en 2017 Japan Atherosclerosis Society This article is distributed under the terms of the latest version of CC BY-NC-SA defined by the Creative Commons Attribution License.http://creativecommons.org/licenses/by-nc-sa/3.0/ |
| spellingShingle | Editorial Yoshida, Hiroshi A First-in-Class Drug, Lomitapide, Tailored to Patients with Homozygous Familial Hypercholesterolemia is Just about Meeting with Good News to Them |
| title | A First-in-Class Drug, Lomitapide, Tailored to Patients with Homozygous Familial Hypercholesterolemia is Just about Meeting with Good News to Them |
| title_full | A First-in-Class Drug, Lomitapide, Tailored to Patients with Homozygous Familial Hypercholesterolemia is Just about Meeting with Good News to Them |
| title_fullStr | A First-in-Class Drug, Lomitapide, Tailored to Patients with Homozygous Familial Hypercholesterolemia is Just about Meeting with Good News to Them |
| title_full_unstemmed | A First-in-Class Drug, Lomitapide, Tailored to Patients with Homozygous Familial Hypercholesterolemia is Just about Meeting with Good News to Them |
| title_short | A First-in-Class Drug, Lomitapide, Tailored to Patients with Homozygous Familial Hypercholesterolemia is Just about Meeting with Good News to Them |
| title_sort | first-in-class drug, lomitapide, tailored to patients with homozygous familial hypercholesterolemia is just about meeting with good news to them |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392476/ https://www.ncbi.nlm.nih.gov/pubmed/28239069 http://dx.doi.org/10.5551/jat.ED069 |
| work_keys_str_mv | AT yoshidahiroshi afirstinclassdruglomitapidetailoredtopatientswithhomozygousfamilialhypercholesterolemiaisjustaboutmeetingwithgoodnewstothem AT yoshidahiroshi firstinclassdruglomitapidetailoredtopatientswithhomozygousfamilialhypercholesterolemiaisjustaboutmeetingwithgoodnewstothem |